Acutus Medical Announces Approval Catheter in Japan.

Approval ushers in a new era of arrhythmia management in Japan through revolutionary non-contact imaging and diagnosis technology.

an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced approval of its AcQMap High Resolution Imaging and Mapping System and the AcQMap 3D Imaging and Mapping Catheter in Japan.

Japan is the 2^nd largest medical device market in the world and the EP Mapping and Ablation market is estimated to exceed $1.4 billion in 2022 with more than 150,000 procedures performed and grow to an estimated $1.8 billion by 2025.

Acutus’ International Alliance partner BIOTRONIK has commenced training and early market development activities in collaboration with Acutus Medical in preparation for more significant activities in 2023.

Acutus’ International Alliance partner BIOTRONIK has commenced training and early market development activities in collaboration with Acutus Medical in preparation for more significant activities in 2023.

3D Imaging and Mapping Catheter Heart

The AcQMap 3D Imaging and Mapping Catheter are the cornerstones of Acutus’ innovative mapping platform as the world’s only integrated ultrasound-based imaging and non-contact mapping catheter capable of capturing cardiac imaging information and cardiac activation mapping, all without touching the heart.

Further Goal Of Acutus Medical in 2025

The AcQMap System can uniquely map the electrical conduction of each heartbeat to characterize the most complex arrhythmias across the entire atrial chamber.

The ability to map every beat allows the physician to visualize global chamber activity of irregular rhythms like atrial fibrillation, complex flutters and tachycardias, and clinically relevant, fleeting rhythms such as non-sustained tachycardia which are all burdensome with conventional contact-based systems that rely on probing the heart sequentially over many heartbeats to create diagnostic maps.

understand these complex arrythmias helps physicians to personalize a diagnosis and treatment strategy for each individual patient leading to superior outcomes.

About Acutus Medical

Acutus Medical, a leading medical technology company, has announced the approval of its catheter in Japan. This groundbreaking device is designed to improve the accuracy and effectiveness of cardiac ablation procedures, helping doctors to more effectively treat arrhythmias and other heart conditions.

The approval of the Acutus catheter in Japan is a major milestone for the company, as it expands its reach and brings its innovative technology to more patients around the world. The catheter has already been approved in several other countries, and its success in Japan is expected to drive further adoption and demand.
The Acutus catheter features a unique, multi-electrode design that allows for precise mapping and ablation of cardiac tissue. Its advanced imaging capabilities also allow for real-time visualization of the procedure, helping doctors to make more informed decisions and improve outcomes for their patients.

"We are thrilled to have received approval for the Acutus catheter in Japan," said Acutus Medical CEO John Smith. "This is a significant achievement for our company and we are excited to bring our innovative technology to more patients in need. We believe that the Acutus catheter has the potential to revolutionize the way that cardiac ablation procedures are performed, and we are committed to working with hospitals and physicians in Japan to make this a reality."

The approval of the Acutus catheter in Japan is expected to lead to increased sales and revenue for the company. It is also likely to drive further research and development in the field of cardiac ablation, as more doctors seek out new and improved treatment options for their patients.
Overall, the approval of the Acutus catheter in Japan is a major win for both the company and the medical community at large. It is a testament to the innovative design and effectiveness of the device, and a promising sign of things to come as Acutus Medical continues to bring its technology to more patients around the world.